UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial

American journal of kidney diseases, 2019-01, Vol.73 (1), p.51-61

2019

Volltextzugriff (PDF)

Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine Concentrations

The New England journal of medicine, 1999-05, Vol.340 (19), p.1449-1454

1999

Volltextzugriff (PDF)

Hypophosphatemic Effect of Niacin in Patients without Renal Failure: A Randomized Trial

Clinical journal of the American Society of Nephrology, 2010-04, Vol.5 (4), p.582-589

2010

Volltextzugriff (PDF)

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations

Circulation (New York, N.Y.), 1996, Vol.93 (1), p.7-9

1996

Volltextzugriff (PDF)

Binder Blinders—Niacin of Omission?

American journal of kidney diseases, 2010-04, Vol.55 (4), p.628-630

Bostom, Andrew G., MD, MS

2010

Volltextzugriff (PDF)

Sustained Hypophosphatemic Effect of Once-Daily Niacin/Laropiprant in Dyslipidemic CKD Stage 3 Patients

American journal of kidney diseases, 2011-06, Vol.57 (6), p.963-965

2011

Volltextzugriff (PDF)

New Evidence for the Phosphorus-Lowering Effects of Niacin

American journal of kidney diseases, 2010-07, Vol.56 (1), p.185-185

Bostom, Andrew G., MD, MS

2010

Volltextzugriff (PDF)

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

The New England journal of medicine, 1995-02, Vol.332 (5), p.286-291

1995

Volltextzugriff (PDF)

Remnant cholesterol is prospectively associated with cardiovascular disease events and all-cause mortality in kidney transplant recipients: the FAVORIT study

Nephrology, dialysis, transplantation, 2022-01, Vol.37 (2), p.382-389

2022

Volltextzugriff (PDF)

Hypothesis: Potential Utility of Serum and Urine Uromodulin Measurement in Kidney Transplant Recipients?

Transplantation direct, 2017-11, Vol.3 (11), p.e219-e219

2017

Volltextzugriff (PDF)

Baseline Characteristics of Participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial

American journal of kidney diseases, 2009-01, Vol.53 (1), p.121-128

2009

Volltextzugriff (PDF)

Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial

Circulation (New York, N.Y.), 2011-04, Vol.123 (16), p.1763-1770

2011

Volltextzugriff (PDF)

Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels

Journal of the American Society of Nephrology, 2002-08, Vol.13 (8), p.2140-2144

2002

Volltextzugriff (PDF)

Physical Activity and Cardiovascular Risk among Kidney Transplant Patients

Medicine and science in sports and exercise, 2019-06, Vol.51 (6), p.1154-1161

2019

Volltextzugriff (PDF)

Physical activity and risk of cardiovascular events and all-cause mortality among kidney transplant recipients

Nephrology, dialysis, transplantation, 2020-08, Vol.35 (8), p.1436-1443

2020

Volltextzugriff (PDF)

Blood Pressure, Chronic Kidney Disease Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT Trial

American journal of hypertension, 2019-08, Vol.32 (9), p.816-823

2019

Volltextzugriff (PDF)

Once-Daily Extended-Release Niacin Lowers Serum Phosphorus Concentrations in Patients With Metabolic Syndrome Dyslipidemia

American journal of kidney diseases, 2011-01, Vol.57 (1), p.181-182

2011

Volltextzugriff (PDF)

Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study

American journal of kidney diseases, 2017-12, Vol.70 (6), p.762-769

2017

Volltextzugriff (PDF)

Homocyst(e)ine, diet, and cardiovascular diseases : A statement for healthcare professionals from the Nutrition Committee, American Heart Association

Circulation (New York, N.Y.), 1999-01, Vol.99 (1), p.178-182

1999

Volltextzugriff (PDF)

Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort

The American journal of clinical nutrition, 2001-03, Vol.73 (3), p.613-621

2001

Volltextzugriff (PDF)

Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes

Kidney international, 1997-07, Vol.52 (1), p.10-20

1997

Volltextzugriff (PDF)

Residual renal function and mortality risk in hemodialysis patients

American journal of kidney diseases, 2001-07, Vol.38 (1), p.85-90

2001

Volltextzugriff (PDF)

Safety events in kidney transplant recipients: results from the folic Acid for vascular outcome reduction in transplant trial

Transplantation, 2015-05, Vol.99 (5), p.1003

2015

Volltextzugriff (PDF)

Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk

Thrombosis and haemostasis, 2002-11, Vol.88 (5), p.799

2002

Volltextzugriff (PDF)

The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: A randomized, controlled study

American journal of kidney diseases, 2003-02, Vol.41 (2), p.442-446

2003

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(107)

Publikationsform

Sprache

Englisch
(131)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial

Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine Concentrations

Hypophosphatemic Effect of Niacin in Patients without Renal Failure: A Randomized Trial

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations

Binder Blinders—Niacin of Omission?

Sustained Hypophosphatemic Effect of Once-Daily Niacin/Laropiprant in Dyslipidemic CKD Stage 3 Patients

New Evidence for the Phosphorus-Lowering Effects of Niacin

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

Remnant cholesterol is prospectively associated with cardiovascular disease events and all-cause mortality in kidney transplant recipients: the FAVORIT study

Hypothesis: Potential Utility of Serum and Urine Uromodulin Measurement in Kidney Transplant Recipients?

Baseline Characteristics of Participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial

Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial

Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels

Physical Activity and Cardiovascular Risk among Kidney Transplant Patients

Physical activity and risk of cardiovascular events and all-cause mortality among kidney transplant recipients

Blood Pressure, Chronic Kidney Disease Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT Trial

Once-Daily Extended-Release Niacin Lowers Serum Phosphorus Concentrations in Patients With Metabolic Syndrome Dyslipidemia

Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study

Homocyst(e)ine, diet, and cardiovascular diseases : A statement for healthcare professionals from the Nutrition Committee, American Heart Association

Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort

Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes

Residual renal function and mortality risk in hemodialysis patients

Safety events in kidney transplant recipients: results from the folic Acid for vascular outcome reduction in transplant trial

Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk

The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: A randomized, controlled study

Suchergebnisse filtern